Quality of life and associated factors of heroin‐dependent patients receiving methadone and buprenorphine maintenance treatment
Open Access
- 13 December 2023
- journal article
- research article
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 43 (4) , 607-615
Abstract
Aim: Although studies in Western countries have investigated the quality of life (QoL) of heroin users, limited research on this topic has been conducted in Asia. The present study assessed QoL in patients with heroin dependence receiving medications to treat opioid use disorder.Methods: We performed a cross‐sectional study of patients with heroin dependence receiving methadone and buprenorphine treatment. The demographic and substance use variables of patients receiving methadone and buprenorphine were compared. The Chinese Health Questionnaire (CHQ‐12), Obsessive Compulsive Drug Use Scale (OCDUS), and World Health Organization Quality of Life Short Form Taiwan version (WHOQOL‐BREF‐T) were administered to measure patient mental health problems, addiction severity, and QoL, respectively. Multivariate regression was used to identify the factors associated with QoL.Results: A total of 149 patients receiving methadone and 31 receiving buprenorphine completed the questionnaires. Individuals in the buprenorphine group were more likely to be married (p = 0.024) or employed (p = 0.024), have a higher educational level (p = 0.013), have lower drug craving (OCDUS: p = 0.035), or have higher QoL (WHOQOL‐BREF‐T: p = 0.004) than those in the methadone group. After adjustment for other variables, employment was positively associated with the physical, psychological, and environmental domains of QoL. Receiving buprenorphine treatment (p = 0.032) and longer treatment duration (p = 0.016) were associated with higher psychological QoL.Conclusion: Several factors were associated with QoL in patients with heroin dependence. Some measures may improve their QoL, such as reducing employment barriers, improving treatment adherence, or increasing accessibility to buprenorphine treatment.Keywords
Funding Information
- Taipei City Hospital (10601‐62‐025, 11201‐62‐025)
- National Science and Technology Council (112‐2314‐B‐532‐003)
This publication has 60 references indexed in Scilit:
- Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatmentQuality of Life Research, 2010
- Measuring Culture Outside the Head: A Meta-Analysis of Individualism—Collectivism in Cultural ProductsPersonality and Social Psychology Review, 2008
- Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatmentDrug and Alcohol Dependence, 2008
- Impact of Substance Dependence and Dual Diagnosis on the Quality of Life of Heroin Users Seeking TreatmentSubstance Use & Misuse, 2008
- Association of Personality Disorders, Family Conflicts and Treatment with Quality of Life in Opiate AddictionEuropean Addiction Research, 2008
- Years of potential life lost among heroin addicts 33 years after treatmentPreventive Medicine, 2007
- Quality of Life Among Heroin Users on Buprenorphine versus Methadone MaintenanceThe American Journal of Drug and Alcohol Abuse, 2007
- Determinants of Health-Related Quality of Life of Opiate Users at Entry to Low-Threshold Methadone ProgramsEuropean Addiction Research, 2006
- Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependenceEuropean Psychiatry, 2004
- Subjective well-being.Psychological Bulletin, 1984